Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Innovative Trial for Understanding the Impact of Targeted Therapies in NF2-Related Schwannomatosis (INTUITT-NF2)

NCT04374305 is registered in ClinicalTrials.gov with Scott R. Plotkin, MD, PhD as lead sponsor.

NCT NCT04374305
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04374305 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Innovative Trial for Understanding the Impact of Targeted Therapies in NF2-Related Schwannomatosis (INTUITT-NF2)
Lead sponsor
Scott R. Plotkin, MD, PhD
Phase
Phase 2
Overall status
Recruiting
Start date
June 20, 2020
Completion date
December 1, 2030
Enrollment
109 (estimated)
Sites
6

Conditions

As the registry lists them; a condition with its own page is linked.

ependymoma, meningioma, neurofibromatosis type 2, non-vestibular schwannoma, vestibular schwannoma